Page 1 of Clinical Trials for clinical tolerability, 6375 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant
Last Updated: January 5, 2012
Condition(s): Hay Fever
2
Completed
Safety and Tolerance Study of Grass Pollen-Derived Peptides to Treat Allergic Rhinitis
Last Updated: January 30, 2009
Condition(s): Seasonal Allergic Rhinoconjunctivitis
3
Active, not recruiting
Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis
Last Updated: November 16, 2011
Condition(s): Grass Pollen Allergy; Hay Fever
4
Active, not recruiting
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
Last Updated: February 10, 2012
Condition(s): Human African Trypanosomiasis
5
Recruiting
Study of Ketamine Administered Intravenously and by Sublingual Wafer
Last Updated: June 20, 2011
Condition(s): Pain
6
Completed
Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis
Last Updated: November 16, 2011
Condition(s): Seasonal Allergic Rhinoconjunctivitis
7
Completed
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
Last Updated: February 6, 2012
Condition(s): Constipation
8
Completed
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
Last Updated: April 9, 2010
Condition(s): Influenza
9
Completed
Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis
Last Updated: February 28, 2011
Condition(s): Seasonal Allergic Rhinoconjunctivitis
10
Completed
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris
Last Updated: March 12, 2009
Condition(s): Psoriasis
11
Terminated
Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis
Last Updated: June 1, 2010
Condition(s): Amyotrophic Lateral Sclerosis
12
Completed
Efficacy and Tolerability of α-galactosidase in Treating Gas-related Symptoms in Children
Last Updated: May 9, 2012
Condition(s): Gas Pain Related Intake
13
Completed
Efficacy and Tolerability of PEG-only Laxative for Fecal Impaction and Chronic Constipation in Children
Last Updated: May 4, 2012
Condition(s): Constipation; Faecal Impaction
14
Completed
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
Last Updated: September 13, 2006
Condition(s): Influenza
15
Completed
Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases
Last Updated: February 20, 2012
Condition(s): Influenza Disease
16
Completed
Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks
Last Updated: June 22, 2010
Condition(s): Malaria
17
Completed
Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.
Last Updated: January 2, 2012
Condition(s): Influenza Disease
18
Completed
AZD5438 in Patients With Advanced Solid Malignancies
Last Updated: January 25, 2011
Condition(s): Neoplasms
19
Terminated
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
Last Updated: January 17, 2012
Condition(s): Rheumatoid Arthritis
20
Completed
Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
Last Updated: May 14, 2009
Condition(s): Hypertension, Pulmonary

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=clinical+tolerability

Page 1 of Clinical Trials for clinical tolerability, 6375 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About